EP3310364A1 — Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infant
Assigned to Pharmacosmos Holding AS · Expires 2018-04-25 · 8y expired
What this patent protects
Title: Iron carbohydrate complex for treatment of fetal metal defi- ciency Disclosed herein is a pharmaceutical composition comprising an iron carbohydrate complex for use in a method for treatment or prevention of an iron deficiency of a fetus or an infant, wherein the iron carb…
USPTO Abstract
Title: Iron carbohydrate complex for treatment of fetal metal defi- ciency Disclosed herein is a pharmaceutical composition comprising an iron carbohydrate complex for use in a method for treatment or prevention of an iron deficiency of a fetus or an infant, wherein the iron carbohydrate complex is administered to the mother of the fetus or infant.
Drugs covered by this patent
- Monoferric (FERRIC DERISOMALTOSE) · Pharmacosmos
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.